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Abstract
Purpose The mechanisms behind trapezius myalgia are
unclear. Many hypotheses have been presented suggesting
an altered metabolism in the muscle. Here, muscle mi-
crodialysate from healthy and myalgic muscle is analysed
using metabolomics. Metabolomics analyse a vast number
of metabolites, enabling a comprehensive explorative
screening of the cellular processes in the muscle.
Methods Microdialysate samples were obtained from the
shoulder muscle of healthy and myalgic subjects that per-
formed a work and stress test. Samples from the baseline
period and from the recovery period were analysed using
gas chromatography—mass spectrometry (GC–MS) toge-
ther with multivariate analysis to detect differences in
extracellular content of metabolites between groups. Sys-
tematic differences in metabolites between groups were
identified using multivariate analysis and orthogonal partial
least square discriminate analysis (OPLS-DA). A
complementary Mann–Whitney U test of group difference
in individual metabolites was also performed.
Results A large number of metabolites were detected and
identified in this screening study. At baseline, no system-
atic differences between groups were observed according
to the OPLS-DA. However, two metabolites, L-leucine and
pyroglutamic acid, were significantly more abundant in the
myalgic muscle compared to the healthy muscle. In the
recovery period, systematic difference in metabolites
between the groups was observed according to the OPLS-
DA. The groups differed in amino acids, fatty acids and
carbohydrates. Myristic acid and putrescine were signifi-
cantly more abundant and beta-D-glucopyranose was sig-
nificantly less abundant in the myalgic muscle.
Conclusion This study provides important information
regarding the metabolite content, thereby presenting new
clues regarding the pathophysiology of the myalgic muscle.
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Introduction
Little is known about the pathophysiological mechanisms
behind work-related disorders, especially regarding chronic
trapezius myalgia. In an attempt to shed light on the bio-
chemistry of myalgic muscle, a number of studies have
employed methodologies such as muscle biopsies and
microdialysis. Results obtained with these methods have
not been conclusive in explaining the peripheral mecha-
nisms of pain, but a generalisation to be made is that evi-
dence favours metabolic and algesic disturbances in the
muscle tissue (Gerdle and Larsson 2012; Visser and van
Dieen 2006).
Biopsy samples of myalgic muscle have shown mor-
phological irregularities. Slow contracting type 1 fibres
were shown to occur to a larger extent in myalgic com-
pared to healthy muscle (Kadi et al. 1998b; Lindman et al.
1991; Andersen et al. 2008c). Also present in myalgic
muscle were aggregations of mitochondria within muscle
cells such as increased prevalence of moth eaten and rag-
ged red fibres (Larsson et al. 1988; Kadi et al. 1998b).
These aggregations are indicative of mitochondrial distur-
bances and believed to be evidence of altered metabolism
in the myalgic muscle. A recent finding of reduced meta-
bolic protein production for myalgic versus healthy muscle
was discussed in the context of differences in mitochon-
drial function between groups (Sjøgaard et al. 2013). The
mitochondrial alterations may via different mechanisms be
linked to pain; for example, increased content of intra-
muscular fat can result in release of pro-inflammatory
substances (cytokines and leptin), increased concentration
of lactate with activation of acid-sensing ion channel 3
(ASIC-3) and reactive oxygen species (ROS) generation
which directly or indirectly interact with the nociceptive
system (for references see Gerdle et al. 2013a, b).
Thus, a link between mitochondrial function and per-
ceived pain has been speculated. However, some results
suggest that moth eaten fibres and ragged red fibres are
related to work exposure, per se, and not to the pain (Kadi
et al. 1998a; Larsson et al. 2000b). These types of morpho-
logical disturbances have also been related to muscle turn-
over due to their high prevalence in muscle dystrophies.
Changes in metabolism have been addressed using the
microdialysis (MD) technique. MD allows for in vivo
collection of extracellular fluid from the interstitium of
muscles, thereby providing access to the chemical changes
in the muscle (Ungerstedt 1991). Comparisons between
myalgic and healthy trapezius muscle at rest, during low-
load repetitive work and recovery have been studied
(Flodgren et al. 2005, 2010; Rosendal et al. 2004a, b,
2005a, b; Sjogaard et al. 2010). In most of these studies,
patients with chronic trapezius myalgia were shown to
have increased interstitial levels of lactate and pyruvate
compared to healthy subjects. Even though increased
anaerobic metabolism has been suggested as an explana-
tion to these findings, the results cannot be explained by
insufficiencies in muscle oxygenation (Sjogaard et al.
2010; Larsson et al. 2008; Andersen et al. 2010). Further-
more, expressions of lactate and pyruvate alone may not
describe the entire picture in the myalgic muscle.
In our opinion, a more comprehensive assessment of the
metabolism in the muscle environment could give credence
to discrepancies seen in the above-mentioned studies, as
well as provide new clues about the mechanism behind
chronic trapezius myalgia. Metabolomics using gas chro-
matography mass spectrometry (GC–MS) is a technique
that screens for a large number of metabolites simulta-
neously. This approach is based on the systematic study of
the unique small-molecule chemical fingerprints that spe-
cific cellular processes leave behind. The metabolites are
the end products of the cellular processes. With meta-
bolomics, a snap-shot of the physiology of the cell is
provided. This technology, ideal for identifying diagnostic
biomarkers, consists of two sequential steps: (1) an
experimental technique, based on MS or nuclear magnetic
resonance spectroscopy, designed to profile low molecular
weight compounds, and (2) multivariate data analysis
(Dunn and Ellis 2005). Metabolomic analysis of biofluids
(e.g. microdialysates) or tissues (e.g. biopsies) has been
successfully used in the fields of physiology, diagnostics,
functional genomics, pharmacology, toxicology and nutri-
tion (Dunn and Ellis 2005). Metabolomics has not previ-
ously been applied when investigating chronic myalgia, but
could add a new dimension in understanding the underly-
ing mechanisms.
The aim of the present study was to use metabolomics to
determine metabolites in the trapezius muscle for a group
of patients with trapezius myalgia in comparison to a
healthy control group. The MD technique was used to
collect dialysate samples before and after a standardised
work and stress test. This allowed for assessment of group
differences as well as differences in metabolite content
following a work and stress task.
Methods
Subjects
Subjects included in this study were from a previous study
in our laboratory that investigated serotonin levels in MD
samples from female subjects with trapezius myalgia and
healthy subjects (Ghafouri et al. 2010; Sjo¨rs et al. 2009).
Eleven subjects with trapezius myalgia (MYA) who had
rated highest pain intensity at the recovery period (see
below) and ten healthy subjects (CON) were selected for
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the present study (Fig. 1). The selection of MYA with
highest pain intensity was done to improve the contrasts
between the two groups of subjects in this original study
aimed at investigating the interstitium of the trapezius
(with and without myalgia) using metabolomics.
Anthropometrics for MYA were mean age 40 years,
mean height 165 cm and mean weight 68 kg, and for CON
were mean age 42 years, mean height 168 cm, and mean
weight 68 kg. The mean body mass indexes (BMI) were
24.0 (SD ± 4.0) and 24.9 (SD ± 3.0) for MYA and CON,
respectively. The MYA group was diagnosed with neck
pain, tightness of the trapezius muscle (i.e. a feeling of
stiffness in the descending region of the trapezius muscle
reported by the subject at examination of lateral flexion of
the head), palpable tender points of the muscle and normal
or slightly decreased range of motion of the cervical col-
umn. A clinical examination protocol allowed the examiner
to identify and exclude subjects with pain in the trapezius
region likely referred from painful tendons or nerve com-
pressions in the neck shoulder area. The median chronic
pain duration in MYA was 105 months (range
36–273 months).
All patients participated voluntarily after informed
consent. The study was approved by the ethical committee
of Linko¨ping University (Dnr M46-07).
General experimental procedure
The experiment was performed 3–4 weeks after clinical
examination and interview. The participants were asked not
to use any medications except for paracetamol preparations
3 days before the day of the experiment, and to refrain
from intake of caffeine and nicotine 12 h prior to the
examination. The subjects were allowed to use paraceta-
mol-based analgesics, since their potential impact on
metabolism is considered to be weak; further, the suggested
mechanism of paracetamol concerns more central pain
mechanism in combination with a weak anti-inflammatory
effect (Graham et al. 2013). Participants were also asked
not to perform any shoulder or neck-straining exercises
48 h before the study, except for ordinary daily work and/
or leisure activities. The participants reported to the labo-
ratory in the morning. They had finished breakfast 1–2 h
before the start of the experiment.
Microdialysis procedure
Two MD catheters (5 and 3,000 kDa cut off) were inserted
into the pars descendens of the trapezius muscle on the
most painful side for the MYA group (in all patients also
the dominant side) and on the dominant side for the CON
group. The site for catheter insertion was at a standardised
location for all subjects. The insertion point was located at
the center of the descending part of the trapezius muscle,
midway between the processus spinosus of the seventh
cervical vertebra and the lateral end of acromion. The skin
and the subcutaneous tissues at the catheters’ entrance and
exit sites were anaesthetised with a local injection
(0.2–0.5 ml) of Xylocaine (20 mg/ml) without adrenaline,
and care was taken not to anaesthetise the underlying
muscle. The distance between the entrance and exit sites of
the catheters in the skin was approximately 7 cm with at
least 5 cm of the catheter in the trapezius muscle ensuring
that the entire 30 mm membrane was situated within the
muscle tissue. The MD catheters were placed in parallel to
the muscle fibres with an inter-catheter distance of
approximately 2 cm between the MD catheters. To facili-
tate the positioning of the MD catheters, the skin at the
entrance point was cautiously punctured with a needle,
which eliminated the toughness of the skin. Thus, a high
control of the tip of the spinal needle was enabled as well
as the possibility to slowly pass through skin, subcutaneous
tissue and fascia and enter the muscle with the spinal
needle. Typically, a brief involuntary contraction and
change of resistance were perceived when the tip of the
spinal needle entered the fascia and muscle. When the
spinal needle was in the correct place, the inner steering pin
was removed and the MD catheter was inserted, after
which the needle was carefully removed. In this study, the
microdialysate from the 3,000 kDa catheter was used. The
MD catheters were perfused with a high-precision syringe
pump (CMA 107; Carnegie Medicine, Solna, Sweden) at a
rate of 5 ll/min with a Ringer acetate solution (Pharmacia
& Upjohn, Copenhagen, Denmark) containing 3 mM glu-
cose and 0.5 mM lactate to minimise the risk of draining
the interstitial space (Lo¨nnroth et al. 1987).
Fig. 1 Mean pain intensity in millimetres on a visual analogue scale
(VAS; mm) for subjects with chronic myalgia (MYA) and controls
(CON). The selection of subjects is based on the pain intensity at
recovery (mean shown by the dark grey bars). Mean ratings at
baseline are shown by the light grey bars. Error bars represent the
standard deviation
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After catheter insertion, the participants rested 120-min
to obtain steady state (Rosendal et al. 2004a; Ernberg et al.
1999), to allow the tissue to recover from possible changes
in the interstitial environment induced by the catheter
insertion (trauma phase). Although no control molecules
for tissue damages were measured, previous studies have
shown that a 120 min rest period after the insertion is
sufficient to allow the levels of inflammatory substances to
return to pre-insertion levels (Flodgren et al. 2005). During
the trauma phase, the subjects were given a standardised
meal that was served 80 min after start of the experiment.
The trauma phase was followed by a 20 min baseline
period, still at rest, where the subjects were instructed to
sit comfortably in an armchair and rest the neck/shoulder
muscles. After this period the subjects preformed a
standardised repetitive arm work for 1 h and 40 min.
Immediately after the work period, a stress test was
implemented. The experiment ended with 80 min of
recovery during which the subjects rested. MD samples
were collected every 20 min. Samples from the baseline
period and the recovery period (pooled for the 60 and
80 min after work time points) were analysed in this
study. For the subjects of both MYA and CON, the
catheters worked well during the entire experiment. For
quality control, each vial (for a particular sample) was
weighed before and immediately after sampling to con-
firm that sampling was working according to the set
perfusion rate.
Work and stress test
A standardised repetitive work was performed using two
standardised Valpar Component Work Stations (VCWS08
and VCWS204, Valpar Tucson, USA) and one peg-board
exercise; these are previously described (Sjo¨rs et al. 2010).
The stations were selected to simulate sedentary or
assembly work that requires unilateral or bilateral use of
upper extremities. The purpose was to exacerbate pain in
the MYA group by performing the work predominantly
with their painful side. The three work portions were per-
formed at a standardised work pace and alternated in
20-min intervals in the sequence; VCWS08—peg-board—
VCWS204—peg-board—VCWS204—peg-board. The
repetitive work test was immediately followed by the Trier
social stress test (TSST) which is a standardised and well-
validated psychosocial stressor (Kirschbaum et al. 1993).
The TSST-test protocol consisted of a 10-min preparatory
and information period followed by a 5 min speech and
5 min verbal arithmetic task. For all subjects, the TSST
took place between 1.30 p.m. and 3.30 p.m. to minimise
confounders from diurnal variation in hormone levels. The
experimental sessions were scheduled day 1–10 in the
menstrual cycle (i.e. the follicular phase).
Processing of samples
Chemicals
The chemicals used for sample preparation were all of
analytical grade, except otherwise stated. The stable iso-
tope-labelled internal standard compound (IS) 13C5-pro-
line, 2H4-succinic acid, 13C5, 15 N-glutamic acid, 1,2,3-
13C3 myristic acid, 2H7-cholesterol and 13C4 disodium
alpha-ketoglutarate were purchased from Cambridge Iso-
tope Laboratories (Andover, MA, USA); 13C12-sucrose,
13C4-palmitric acid and 2H4-butanediamine.2HCl were
from Campro (Veenendaal, The Netherlands); 13C6-glu-
cose was from Aldrich (Steinheim, Germany) and 2H6-
salicylic acid was from Icon (Summit, NJ, USA). Stock
solutions of the IS were prepared either in purified and
deionised water (Milli-Q, Millipore, Billerica, MA, USA)
or in Methanol (J.T.Baker, Deventer, Holland) at the same
concentration 0.5 microgram per microlitre. Metyl stearate
was purchased from Sigma (St. Louis, MO, USA). N-Me-
tyl-N-trimethylsilyltriflouroacetamide (MSTFA) with 1 %
trimethylchlorosilane (TMCS) and pyridine (silylation
grade) was purchased from Pierce Chemical Co.; heptane
was purchased from Fisher Scientific (Loughborough, UK).
Sample preparation
Prior to extraction, samples were allowed to thaw at room
temperature and then put on ice. Next 225 ll of the
extraction buffer (methanol/water 9:1, with 1 l IS each of
the concentration 7 ng/ll) was added to 50 ll of the mi-
crodialysate. Samples from the recovery period were
pooled taking 25 ll from each of the samples from 60 and
80 min after work and TSST. The mixtures were vortexed
for approximately 10 s and extracted in a bead mill
(MM301 vibration mill, Retsch GmbH & Co. KG, Haan,
Germany) at 30 Hz for 2 min. After 2 h at 4 C on ice,
samples were centrifuged at 14,000 rpm for 10 min at
4 C. A 100-ll aliquot was transferred to a GC vial and
evaporated using a speedvac to dryness. Methoxymation
with 30 ll methoxyamine solution in pyridine (15 lg/ll)
was carried out in room temperature for 1 h, after which
30 ll of heptanes (with 0.5 lg of methyl stearate as
injection IS) was added (Trygg et al. 2005; Wibom et al.
2010).
GC–MS
A 1-ll aliquot of derivatised sample was injected in split-
less mode by Agilent 7683 Series autosampler (Aligent,
Atlanta, GA, USA) into an Aligent 6980 GC equipped with
a 10 m 9 0.18 mm i.d. fused-silica capillary column
chemically bonded with 0.18 lm DB5-MS stationary phase
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(J&W Scientific, Folsom, CA, USA). The injector tem-
perature was 270 C. The carrier gas was helium, set at a
constant flow of 1 mL/min through the purge flow rate of
20 ml/min and an equilibrant time of 1 min. The column
temperature was initially kept at 70 C for 2 min and then
increased from 70 to 320 C at 30 C/min, where it was
kept for 2 min. The effluent from the column was intro-
duced to the ion source of Pegasus III TOFMS (Leco Corp.,
St Joseph, MI). The transfer temperature was set at 250 C
and the ion source temperature at 200 C. Ions were gen-
erated by a 70 eV electron beam at a current of 2.0 mA.
Masses were acquired from m/z 50 to 800 at a rate of 30
spectra per second, and the acceleration voltage was turned
on after a solvent delay of 165 s. Retention indexes were
calculated from the retention times obtained from the
injection of a homologous series of n-alkanes (C12–C32) for
each batch. All samples were run in randomised order
(Wibom et al. 2010).
Hierarchical multivariate curve resolution
Analysing complex samples gives rise to overlapping peaks
in the GC chromatograms and thus mixed mass spectra
from the TOF–MS analysis. To solve this problem, a
multivariate curve resolution method named hierarchical
multivariate curve resolution (H-MCR) has been applied.
In short, the H-MCR generates a matrix where all MD
samples are described by a common set of variables, each
representing one metabolite (Jonsson et al. 2005). The data
can then be subjected to multivariate data analysis as
presented below. A recently implemented internal valida-
tion step in the H-MCR algorithm assures extraction of
robust and reliable metabolite profiles (Thysell et al. 2012).
Together GC–MS and H-MCR constitute a reproduc-
ible platform that allows for generation of global meta-
bolomics for multiple sample comparisons within and
between sample batches (Jonsson et al. 2006; Thysell et al.
2012).
Statistics
Data from samples collected from patients with chronic
trapezius myalgia were compared to the group of healthy
subjects during either baseline or recovery.
Systematic differences—orthogonal partial least-squares
To analyse for systematic differences in metabolite con-
tent, the metabolite data were modelled and interpreted for
the complex interactions acquired in this study using
orthogonal partial least-squares with discriminant analysis
(OPLS-DA) (Trygg and Wold 2002). In data-sets from
GC–TOF–MS analysis of metabolites, the number of
variables (metabolites) greatly exceeds the number of
observation and the variables are often highly correlated.
The multivariate projection method OPLS-DA used in this
study has the advantage of being able to deal with such data
and also to separate the variability among the metabolites
that is directly related to group separation from variability
not related to group separation.
In more detail, OPLS-DA is a supervised multivariate
data projection method used to relate a set of predictor
variables (X or metabolites in this study) to a response
matrix (Y) that represents predefined sample classes
(myalgic or healthy). This method can then be used to
predict class identity and to extract specific features among
the predictor variables (metabolites) distinguishing
between the predefined sample classes. OPLS operates by
dividing the systematic variation in X into two parts: one
part is the linearity related to Y, and thus can be used to
predict Y, and one part is uncorrelated (i.e. orthogonal) to
Y. In this process, each variable in X is associated with a
weight w* for each model component, which represents the
variable’s covariation with Y in that component. Also, each
variable is assigned an OPLS-DA variable importance in
the projection (VIP) value. Since VIP accounts for the
variable importance using all model components (predic-
tive and orthogonal), in models with more than one com-
ponent, VIP does not directly relate to the predictive
component in the model. In this study, a VIP value above
1.0, in combination with w* for the predictive component,
was used to highlight significant metabolites or metabolite
patterns. Metabolites which contributed to the explanation
of group affiliation are presented in Table 1.
Data pretreatment and analysis strategies
The data matrix (X) produced by H-MCR was scaled to
unit variance and screened for inconsistencies, using both
principal component analysis (PCA) (Trygg and Wold
2002) and OPLS-DA.
Single metabolite analysis
Prior to the analysis, the data were tested for normal distri-
bution using Kolmagorov–Smirnov resulting in all metab-
olites being analysed using non-parametric Mann–Whitney
U test. The two-tailed significance level was set to a = 0.05.
Results
The metabolomics approach could identify 74 metabolites
in the interstitium fluid of human trapezius muscle. The
majority of metabolites belonged to amino acids, fatty
acids and carbohydrates.
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Baseline
Microdialysate from healthy (CON) and myalgic (MYA)
trapezius muscle was analysed for metabolite content; two
of the controls were excluded due to the insufficient
amount of dialysate at baseline. The OPLS-DA of group
affiliation (MYA or CON) using the metabolites as
regressors did not generate an explanatory model.
According to the Mann–Whitney U test, two metabolites
differed significantly, with higher abundances in the
interstitium of the MYA muscle: L-leucine (p = 0.041) and
pyroglutamic acid (p = 0.034).
Table 1 All identified metabolites with OPLS loadings value (w*)
and variable of importance in the projection (VIP) value. Principal
abundance of the metabolite in controls (CON) and patients experi-
encing trapezius myalgia (MYA); where negative loading values (w*)
refers to a higher occurrence in MYA and positive loadings refers to a
higher occurrence in CON. Metabolites with w* [ 0.1 are given in
bold. Metabolites were tested for their significance according to
Mann–Whitney U test and are given an * in the table if considered
significant (p [ 0.05)
ID Metabolite w*(MYA/CON) VIP
Amino acids
1 L-Alanine -0.028 0.366
16 L-Valine 0.019 0.251
22 L-Leucine -0.021 0.281
26 Isoleucine 0.034 0.444
27 L-Proline 0.091 1.196
28 Glycine 0.031 0.407
37 Glutamic acid 0.011 0.150
38 L-serine 0.028 0.363
43 Glutamic acid 0.033 0.435
46 Threonine. DL- -0.043 0.567
59 L-Glutamine 0.106 0.373
68 L-Glutamic acid 0.085 1.123
69 Pyroglutamic acid 0.010 0.135
80 Glutamine -0.021 0.279
81 L-Tyrosine 0.046 0.607
86 Ornithine -0.022 0.286
87 L-Glutamic acid 0.073 0.958
88 Phenylalanine 0.052 0.678
98 Putrescine* 0.177 2.327
99 Putrescine 0.068 0.889
106 Arginine -0.027 0.358
116 L-Lysine 0.011 0.150
117 Tyrosine -0.018 0.239
118 Tyrosine -0.044 0.582
141 Phenylalanine -0.017 0.220
146 L-Cystine -0.059 0.777
Carbohydrates
31 Glyceric acid 0.020 0.264
85 D-Ribofuranose 0.040 0.525
91 Zylose 0.056 0.738
95 Xylose 0.035 0.462
96 1.6-anhydro-beta-D-Glucose -0.013 0.171
97 Arabitol 0.101 1.334
104 Arabitol 0.009 0.113
107 Glucose -0.093 1.229
112 Glucose 0.140 1.841
113 Galactose -0.028 0.363
114 Glucose 0.098 1.291
115 Glucose -0.005 0.064
120 Myo-Inositol -0.087 1.144
Table 1 continued
ID Metabolite w*(MYA/CON) VIP
125 Beta-D-Glucopyranose* -0.164 2.156
129 Beta-D-Methylglucopyranoside -0.046 0.608
135 Myo-inositol 0.011 0.145
156 Glucose 0.087 1.151
157 Maltose 0.036 0.482
172 Maltotriose 0.014 0.184
Fatty acids
6 Butanoic acid -0.065 0.852
9 2-Aminobutyric acid -0.035 0.467
23 Glycerol 0.123 1.614
94 Lauric acid 0.033 0.435
105 Glycerol 0.077 1.012
109 Myristic acid* 0.163 2.140
110 Myristic acid 0.101 1.332
111 Myristic acid 0.038 0.498
130 Palmitic acid 0.079 1.040
133 Palmitic acid, trimethylsilyl ester 0.008 0.101
137 Stearic acid methyl ester 0.103 1.361
Other
11 Urea -0.037 0.491
21 Urea -0.085 1.121
24 Phosphoric acid -0.003 0.036
29 Succinic acid 0.068 0.894
47 Lactic acid -0.056 0.738
53 2.5-Diaminovalerolactam -0.028 0.373
64 Salicylic acid 0.048 0.626
65 Salicylic acid 0.028 0.374
66 Salicylic acid 0.195 2.566
67 Salicylic acid 0.002 0.0280
73 Creatinine -0.039 0.517
75 Alpha-Ketoglutarate 0.127 1.672
76 Alpha-Ketoglutarate 0.015 0.201
124 D-Galactono-1.4-lactone -0.097 1.281
136 Uric acid 0.036 0.477
153 Pyruvic acid 0.039 0.516
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Recovery
It was possible to distinguish the two groups of subjects
based on systematic difference in metabolites using OPLS-
DA (Model characteristics: R2 = 0.532 and Q2 = 0.295)
(Fig. 2). In Fig. 2, the separation of the two groups is vis-
ualised in the OPLS-DA score plot. This metabolomics
approach allowed us to identify a number of metabolites that
in the multivariate context differed in abundance between
MYA and CON. Figure 3 shows metabolites plotted
according to their loading weight value (w*) and including
their identification number. The detected metabolites toge-
ther with the metabolites of interest are listed in Table 1.
The metabolite content in the muscle interstitium dif-
fered between CON and MYA with respect to the abun-
dance of amino acids, fatty acids, carbohydrates and other
metabolites (Table 1). In MYA, there was an increased
abundance of amino acids (sorted in descending order
according to w*): Putrescine, L-Glutamine, L-Proline, and
L-Glutamic acid; carbohydrates: Glucose and Arabitol;
fatty acids: Myristic acid, Glycerol, Stearic acid, and Pal-
mitic acid. In CON, there was an increased abundance of
carbohydrates: beta-D-Glucopyranose, D-Galactono-1.4-
lactone, Glucose, and Myo-Inositol. Other metabolites of
interest were: Alpha-Ketoglutarate—more abundant in the
interstitium of MYA, and Urea—more abundant in the
interstitium of CON. Some metabolites were detected
several times as in Table 1. According to Mann–Whitney
U tests two metabolites were significantly more abundant
in the interstitium of MYA—myristic acid (p = 0.043) and
putrescine (p = 0.013), while in the interstitium of CON
glucopyranose (p = 0.006) was significantly more
abundant.
Discussion
This study presents a novel approach in using metabolo-
mics to analyse microdialysates collected from myalgic
and healthy muscles. Microdialysates were collected from
Fig. 2 OPLS-DA model of
controls (CON) and patients
with chronic trapezius myalgia
(MYA) at recovery. Hence, the
plot describes the multivariate
relationships between subjects
and groups. Red diamonds
represent CON and green
circles MYA.
(R2(cum) = 0.532 and
Q2 = 0.295, R2 predictive
component = 0.071 and R2 two
orthogonal components 0.461).
t[1] is the score value of the
predictive component and to[1]
is the score value of the first
orthogonal component
Fig. 3 OPLS-DA loadings plot
of the analysed metabolites:
fatty acids, carbohydrates,
proteins and other metabolites.
Black dots represent protein
metabolites, orange squares
fatty acids and green diamonds
carbohydrates and blue
triangles other metabolites:
Metabolites more abundant in
MYA (VIP [ 1 and w* [ 0.1)
and metabolites more abundant
in CON (VIP [ 1 and w* \
-0.1) are visualised here
outside the grey area and listed
in Table 1. Round unfilled
circles represent unidentified
metabolites
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extracellular space in the trapezius muscle before (base-
line) and after (recovery) exposure to a standardised work
and stress test. Systematic differences in the abundance of
metabolite content were visualised in multivariate models
when many possibly inter-related metabolites in the sam-
ples differed between the groups. To analyse for differ-
ences in content of individual metabolites, the Mann–
Whitney U test was applied.
The extracellular content of metabolites reflects intracel-
lular processes of the muscle or other adjacent cells and may
also be consequences of systemic processes. Previous met-
abolomic studies regarding muscle activity and metabolism
have foremost been performed in exercise studies (Yan et al.
2009; Chorell et al. 2009, 2012; Pohjanen et al. 2007).
Baseline
Pyroglutamic acid and L-Leucine were the two metabolites
with a significantly increased abundance in the MYA at
baseline compared to CON. Pyroglutamic acid is a ring-
like formation of glutamate (Katchalsky and Paecht 1954)
and is considered an intermediate acting as a reservoir for
glutamate (Abraham and Podell 1981). Glutamate is a
peripheral and central neurotransmitter involved in differ-
ent aspects of pain, e.g. long-term potentiation (reviewed
by Miller et al. 2011). Glutamate is released from periph-
eral afferent nerve terminals (Svensson et al. 2003) and
receptors are located on the peripheral ends of small-
diameter primary afferents. When glutamate is released
into the synaptic cleft, nociceptors are activated (Miller
et al. 2011; Coggeshall and Carlton 1998). As visualised in
Table 1, MYA rated higher pain in the trapezius compared
to CON. Two previous studies showed an increased
abundance of glutamate in the interstitium of MYA (Ro-
sendal et al. 2004b; Larsson et al. 2008) which may be in
coherence with our findings. In the OPLS-DA model
concerning recovery, a-ketoglutarate was a metabolite of
interest more abundant in the interstitium of MYA
(Table 1). In addition, the synthesis of a-Ketoglutarate, a
key intermediate in the TCA cycle, occurs by transami-
nation of glutamate or through the action of glutamate
dehydrogenase on glutamate. Other amino acids related to
glutamate, L-glutamine and L-glutamic acid were also more
abundant in the MYA group at recovery.
The role of L-leucine in muscle remodelling in myalgic
muscle has, to our knowledge, not been investigated.
However, in a study by Mackey et al., an increased number
of satellite cells was found in the myalgic trapezius muscle
indicating a greater potential or need for remodelling
(Mackey et al. 2010), which is in agreement with the higher
abundance of L-Leucine in the present study. L-Leucine is
an essential amino acid (EAA) shown to remodel human
skeletal muscle through phosphorylation of the mammalian
target of rapamycin (mTOR) and the subsequent phos-
phorylation of the 70 kD S6 protein kinase (Greiwe et al.
2001; Blomstrand and Essen-Gustavsson 2009). Also,
L-Leucine has been suggested to stimulate glycogen syn-
thesis through activation of glycogen synthase kinase-3
(Peyrollier et al. 2000). High initial concentrations of
muscle glycogen stimulate glycogen breakdown (Hespel
and Richter 1992). This coincides with a recent finding
where higher abundances of glycogen phosphorylase and
phosphoglucomutase-1 were shown in myalgic muscle
biopsies (Hadrevi et al. 2013).
Recovery
Previous studies have implied that some interstitial sub-
stances in myalgic muscle had not returned to baseline
values after 60 min of rest following a low level repetitive
work (Sjogaard et al. 2010; Flodgren et al. 2010; Rosendal
et al. 2004b). In the present study, the recovery sample was
collected as a pooled sample 60 and 80 min at the end of
the work and stress test. In agreement with earlier studies
on single metabolites (Sjogaard et al. 2010; Flodgren et al.
2010), differences in the metabolite pattern between heal-
thy and myalgic muscles were visualised in the explanatory
OPLS-DA models at recovery (Figs. 2, 3). This systematic
difference in metabolite content suggests an altered
metabolite patterns during recovery after the work and
stress provocation. The differences in metabolite content
between groups during recovery but not at baseline may
indicate a need for a sufficient provocation of the muscular
system to detect systematic effects in a relatively limited
number of subjects.
Fatty acids and carbohydrates
According to the OPLS-DA model glycerol, palmitic acid
(hexadecanoic acid), stearic acid (octadecanoic acid) and
myristic acid (tetradecanoic acid) were more abundant in
the extracellular compartments of MYA (Table 1). In
addition, myristic acid (tetradecanoic acid) was significant
also in the univariate test.
Glycerol found in the interstitium of the muscle is the-
oretically produced by the hydrolysis of triglycerides of
muscle cells, plasma lipoproteins and adipocytes (Sjostrand
et al. 2002). Increased levels of muscle glycerol have been
shown in contracting muscle from patients with lactate
dehydrogenase deficiency (Kanno and Maekawa 1995), in
working leg muscle (van Hall et al. 2002) and during low
exercise intensity (Stallknecht et al. 2004).
Stearic acid and palmitic acid are substrates for syn-
thesis of the bioactive lipid molecules related to pain
sensations; N-Palmitoylethanolamide (PEA) and N-stea-
rolethanolamide (SEA). SEA is endocannabinoid-like fatty
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acids that induces analgesic effects (Maccarrone et al.
2002). PEA has been reported as an anti-inflammatory and
anti-nociceptive agent (Calignano et al. 2001; Darmani
et al. 2005). Elevated levels of these substances have
recently been found in myalgic women compared to heal-
thy controls (Ghafouri et al. 2011).
One of the suggested contributing mechanisms to tra-
pezius myalgia is stress (Lundberg et al. 1999; Knardahl
2002). Also, patients suffering from chronic trapezius
myalgia are exposed to physiological stress due to sus-
tained pain. During acute physiological stress, the metab-
olism is altered, as an increase in the breakdown of fat (the
lipolysis) due to adrenergic mechanisms (Hagstrom-Toft
et al. 1993). An increased drive of the sympathetic nervous
system (SNS) also facilitates lipid mobilisation (Coppack
et al. 1994; Bickerton et al. 2008). Though, after repeated
adrenalin treatment, a suppression of the basal and adren-
aline-stimulated lipolysis has been observed (Townsend
et al. 1994). Also, in vitro studies have shown that targets
cells become desensitised after sustained changes in SNS
activity or plasma catecholamine levels, as in chronic stress
situations (Lafontan and Berlan 1993). The excess amount
of fatty acids abundant in the interstitium of MYA during
the recovery phase might fit with the explanation that there
is a desensitisation of the target cells (the muscle cells) due
to the physiological adaptations to prolonged stress
(Townsend et al. 1994). Additionally, studies made on
patients with chronic pain conditions show an increased
intramuscular fat content, i.e. between the muscle cells
(Gerdle et al. 2013a; Elliott et al. 1976). Also, a recent
study shows down-regulated mRNA content of pyruvate
dehydrogenase (PDH-E1a) (Sjøgaard et al. 2013). A pos-
sible explanation to this could be an increased fatty acid
metabolism providing the citric acid cycle with Acetyl-
CoA. Carbohydrate metabolism is also affected by chronic
stress, although no such conclusion could be made from the
results presented here, since in the OPLS-DA model glu-
cose metabolites did appear in both MYA and CON. Also,
glucopyranose which is a cyclised sugar metabolite was
significantly more abundant in CON according to the
Mann–Whitney U test.
Amino acids
Putrescine, L-ornithine, L-arginine and spermidine (not
detected in this analysis) are polyamine amino acids.
Putrescine was significantly more abundant in MYA at
recovery according to the univariate test. Putrescine is
synthesised from L-arginine via L-ornithine (Pegg 2009)
and is transported in and out over cell membranes energy-
dependant (Pegg 1988; Seiler and Dezeure 1990). It is an
extracellular marker of muscle turnover and an indicator of
muscle growth rate (Lee and MacLean 2011). Increased
polyamine levels in skeletal muscle have previously been
found in patients suffering from Duchenne muscle dys-
trophy (Kaminska et al. 1981), which is associated with
high muscle turnover and connective tissue proliferation
(Kaminska et al. 1981). Also limb girdle patients with
enlarged and split muscle fibres with widespread regener-
ation and degeneration express higher levels of polyamines
(Kaminska et al. 1981; Rudman et al. 1980). Hence, an
increased abundance of polyamines is indicative of a
higher muscle turnover in myalgic patients compared with
healthy. Interestingly, Mackey et al. recently reported that
type 1 muscle fibres in the trapezius of subjects with
chronic myalgia have higher density of satellite cells, and
myonuclei gives support to increased myogenic activity
(Mackey et al. 2010).
Experimental design
Pyruvate and lactate have previously been considered bio-
markers of chronic myalgia (Gerdle and Larsson 2012). In
the present study, neither lactate nor pyruvate occurred as of
interest in the OPLS-DA model or the additional univariate
analysis at baseline. At recovery, the metabolites were
detected in the analysis but did not appear as of interest
(Table 1). One possibility is that lactate was, in fact, ele-
vated in myalgic muscles at the end of the work period but
had time to normalise during the stress test, when muscle
activity was low. Another possibility is that the provocation
of the muscle was not large enough in this experiment. In the
previously presented studies, there were different experi-
mental settings when significant changes in pyruvate and
lactate concentrations at baseline were detected. The work
stations in the present study were chosen to mimic low-load
repetitive work, similar to industrial assembly work, with an
intensity that was tolerable to the patients for relatively long
time. The PEGs and handles used in other repetitive work
simulations have had a higher weight, 100 g (Sjogaard et al.
2010) and 130 g (Flodgren et al. 2010) compared to the
PEGs used in this study with a 10 g weight. In reality, the
weight experienced by the subject was greater than 10 g
considering also the weight of the arm; this applies, how-
ever, to all studies of this type. Studies using 23 g weights
(Rosendal et al. 2004a, b) did not obtain increased lactate
and pyruvate concentrations in the recovery phase which is
in accordance with the results presented here. Thus, higher
loads are possibly needed to elicit such metabolic changes
and lactate and pyruvate might be markers of the myalgic
muscles response to work load rather than pain sensations.
But, on the other hand, several studies of chronic trapezius
myalgia have reported significantly increased concentra-
tions of these metabolites at baseline (Rosendal et al. 2004a,
b). Changes in metabolites between healthy and myalgic
muscle in the recovery phase could potentially be due to
Eur J Appl Physiol (2013) 113:2977–2989 2985
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differences in blood flow clearance of metabolites from the
muscle. However, altered in blood flow has been foremost
observed during exercise or mental tasks. The samples in
our study were collected 60–80 min at the end of the
intervention, when there were no differences in potential
hemodynamic parameters (Elcadi et al. 2013).
Moreover, systematic alterations in metabolites were
found according to the OPLS-DA model, implying that the
metabolism is still affected by the previous work and stress
intervention. Another explanation was that the patients
with pain had a lower severity than in earlier studies due to
the fact that the procedures with potential to induce
increased pain intensity were relatively extensive, which in
turn may have created a selection of patients.
Pain intensity (Fig. 1) during the work and stress test was
higher in MYA compared CON, and the work test did elicit
a significant increase in pain in the patient group (Sjo¨rs et al.
2009), which is an important factor separating groups and
attributing the present study as a pain and stress study.
Methodological considerations
The detection of metabolites is in many ways dependent on
dietary intake. In this study, a fixed meal was served during
the experiments which would help control for dietary
metabolites; however, it is possible that metabolites from
diet could linger in the system for longer times which can
compromise the analysis.
Also, the physical activity patterns, per se, for whole
body or only regarding the trapezius muscle can differ
between patients and controls (Andersen et al. 2008a, b).
However, strength and/or endurance were not measured so
we cannot be sure of the contribution in the present study.
A lower physical activity pattern can also be the conse-
quence of pain, i.e. deconditioning. Physical activity has an
effect on, for example, the fatty acid metabolism, as it
affects the beta-oxidation (Konig et al. 2003). Studies that,
to a large extent, control for work exposure, physical fit-
ness and weekly dietary intake are likely preferred but
difficult to achieve. On the other hand, the activity pattern
of the trapezius muscle may be higher or more prolonged in
MYA than in CON (Sjo¨rs et al. 2009; Peolsson et al. 2008;
Larsson et al. 2000a; Elert et al. 1992).
In investigations of metabolic patterns and potential
metabolic markers-based projection models, interpretation
of what variable is important must be made with caution.
VIP [ 1 is generally accepted as criteria for selecting a
variable (Eriksson et al. 2001). Also, in models with more
than one component, VIP might not give the correct rela-
tionship between the pattern of variables and response (Y).
In the case of OPLS-DA loading, weights of the predicative
component will always give a correct relationship; how-
ever, there are difficulties in defining a threshold based on
loading weights [for review Mehmood et al. (2012)]. Thus,
in the present study, a combination of VIP and the weights
of the predictive component were used.
Conclusions
Since previous studies analysing metabolite content in
myalgic muscle have focused only on a few metabolites,
e.g. lactate, pyruvate, glutamate and glucose, the present
study serves as a complement elucidating the possible
systematic changes in metabolites. Previous comparisons
between healthy and myalgic muscle during low-load
repetitive work show that low-intensity activation evokes
no prolonged change in single metabolite content in the
myalgic muscle (Rosendal et al. 2004a, b). However, in our
study, changes in single metabolites during baseline were
detected. Also, single metabolite and systematic changes
after the low intensity work and stress tests were found in
the muscle interstitium. The metabolomics technique
enables a comprehensive analysis of the muscle microdi-
alysate. The physiological effects after stress and pain
induced low-load work were detected showing systematic
changes in metabolites.
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